Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes

ISSN： 0741-238X

Source： Advances in Therapy, Vol.31, Iss.3, 2014-03, pp. : 289-317

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Incretin-based therapies and their future in Type 2 diabetes mellitus

By Sonnett Travis E Robinson Jennifer D Bowen Kurt A

Therapy, Vol. 8, Iss. 2, 2011-03 ,pp. : 143-152

Future Medicine

Access to resources Recommend Favorite

Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies

By Meece Jerry

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 933-944

Informa Healthcare

Access to resources Recommend Favorite

Incretin‐based medications for type 2 diabetes: an overview of reviews

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 7, 2015-07 ,pp. : 649-658

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implications of incretin‐based therapies on cardiovascular disease

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 5, 2015-05 ,pp. : 531-549

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical trials and clinical practice ‐ bridging the gaps in type 2 diabetes. An evidence‐based approach to risk factor modification in type 2 diabetes

INTERNAL MEDICINE JOURNAL, Vol. 30, Iss. 4, 2000-08 ,pp. : 483-491

John Wiley & Sons Inc

Access to resources Recommend Favorite